GREENLAND MINES LTD Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
GREENLAND MINES LTD (GRML) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 5.40% for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-05-23
- GREENLAND MINES LTD share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 5.40%, a 13.92% increase year-over-year.
- GREENLAND MINES LTD share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 4.74%.
- GREENLAND MINES LTD share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 2.97%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | 5.40% 10-Q · filed 2024-05-23 | ||||
| 2023-12-31 | 3.51% 10-Q · filed 2024-05-23 | ||||
| 2023-09-30 | 5.24% 10-Q · filed 2023-11-17 | ||||
| 2023-06-30 | 6.36% 10-Q · filed 2023-08-21 | ||||
| 2023-03-31 | 4.74% 10-Q · filed 2023-05-24 | ||||
| 2022-12-31 | 2.97% 10-K/A · filed 2023-10-18 | 2.97% 10-K · filed 2024-04-17 | |||
| 2022-09-30 | 2.32% 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 33.07% 10-Q · filed 2022-08-15 | ||||
| 2022-04-04 | 25.62% 10-Q · filed 2023-11-17 | 25.62% 10-K/A · filed 2023-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |